Record Details

Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group

CGSpace

View Archive Info
 
 
Field Value
 
Title Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group
 
Creator Baker, K.S.
Jauneikaite, E.
Nunn, J.G.
Midega, J.T.
Atun, R.
Holt, K.E.
Walia, K.
Howden, B.P.
Tate, H.
Okeke, I.N.
Carattoli, A.
Hsu, L.Y.
Hopkins, K.L.
Muloi, Dishon
Wheeler, N.E.
Aanensen, D.M.
Mason, L.C.E.
Rodgus, J.
Hendriksen, R.S.
Essack, S.Y.
Egyir, B.
Halpin, A.L.
MacCannell, D.R.
Campos, J.
Srikantiah, P.
Feasey, N.A.
Peacock, S.J.
SEDRIC Genomics Surveillance Working Group
 
Subject antimicrobial resistance
genomics
 
Description Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR.

This is the first in a Series of five papers about harnessing genomics for antimicrobial resistance surveillance. All papers in the Series are available at www.thelancet.com/microbe.
 
Date 2023-12
2023-11-15T09:16:51Z
2023-11-15T09:16:51Z
 
Type Journal Article
 
Identifier Baker, K.S., Jauneikaite, E., Nunn, J.G., Midega, J.T., Atun, R., Holt, K.E., Walia, K., Howden, B.P., Tate, H., Okeke, I.N., Carattoli, A., Hsu, L.Y., Hopkins, K.L., Muloi, D.M., Wheeler, N.E., Aanensen, D.M., Mason, L.C.E., Rodgus, J., Hendriksen, R.S., Essack, S.Y., Egyir, B., Halpin, A.L., MacCannell, D.R., Campos, J., Srikantiah, P., Feasey, N.A. and Peacock, S.J. for the SEDRIC Genomics Surveillance Working Group. 2023. Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group. Lancet Microbe 4(12): e1035–e1039.
2666-5247
https://hdl.handle.net/10568/134502
https://doi.org/10.1016/S2666-5247(23)00281-1
 
Language en
 
Rights CC-BY-4.0
Open Access
 
Format e1035–e1039
 
Source Lancet Microbe